This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 2018, 68(6):394–424.BrayFFerlayJSoerjomataramISiegelRLTorreLAJemalAGlobal cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA: a cancer journal for clinicians201868639442410.3322/caac.21492Search in Google Scholar
Mokhatri-Hesari P, Montazeri A: Health-related quality of life in breast cancer patients: review of reviews from 2008 to 2018. Health Qual Life Outcomes 2020, 18(1):338.Mokhatri-HesariPMontazeriAHealth-related quality of life in breast cancer patients: review of reviews from 2008 to 2018Health Qual Life Outcomes202018133810.1186/s12955-020-01591-xSearch in Google Scholar
Bonnetain F, Borg C, Adams RR, Ajani JA, Benson A, Bleiberg H, Chibaudel B, Diaz-Rubio E, Douillard JY, Fuchs CS et al: How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials. Annals of oncology : official journal of the European Society for Medical Oncology 2017, 28(9):2077–2085.BonnetainFBorgCAdamsRRAjaniJABensonABleibergHChibaudelBDiaz-RubioEDouillardJYFuchsCSHow health-related quality of life assessment should be used in advanced colorectal cancer clinical trialsAnnals of oncology : official journal of the European Society for Medical Oncology20172892077208510.1093/annonc/mdx191Search in Google Scholar
Velikova G, Coens C, Efficace F, Greimel E, Groenvold M, Johnson C, Singer S, van de Poll-Franse L, Young T, Bottomley A: Health-Related Quality of Life in EORTC clinical trials — 30 years of progress from methodological developments to making a real impact on oncology practice. European Journal of Cancer Supplements 2012, 10(1):141–149.VelikovaGCoensCEfficaceFGreimelEGroenvoldMJohnsonCSingerSvan de Poll-FranseLYoungTBottomleyAHealth-Related Quality of Life in EORTC clinical trials — 30 years of progress from methodological developments to making a real impact on oncology practiceEuropean Journal of Cancer Supplements201210114114910.1016/S1359-6349(12)70023-XSearch in Google Scholar
EORTC. EORTC QLQ-C30 (Version 3). EORTC Study Group on Quality of Life. 1995 [https://qol.eortc.org/]EORTCEORTC QLQ-C30 (Version 3)EORTC Study Group on Quality of Life1995[https://qol.eortc.org/]Search in Google Scholar
EORTC. EORTC QLQ-BR23. (version 1). EORTC Study Group on Quality of Life. 1994 [https://qol.eortc.org/]EORTCEORTC QLQ-BR23. (version 1)EORTC Study Group on Quality of Life1994[https://qol.eortc.org/]Search in Google Scholar
Perez EA: Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer. Annals of Oncology 2007, 18:viii26–viii35.PerezEASafety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancerAnnals of Oncology200718viii26viii3510.1093/annonc/mdm263Search in Google Scholar
van Nes JGH, Fontein DBY, Hille ETM, Voskuil DW, van Leeuwen FE, de Haes JCJM, Putter H, Seynaeve C, Nortier JWR, van de Velde CJH: Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study. Breast Cancer Research and Treatment 2012, 134(1):267–276.van NesJGHFonteinDBYHilleETMVoskuilDWvan LeeuwenFEde HaesJCJMPutterHSeynaeveCNortierJWRvan de VeldeCJHQuality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side studyBreast Cancer Research and Treatment2012134126727610.1007/s10549-012-2028-2Search in Google Scholar
Gianni L, Dafni U, Gelber RD, Azambuja E, Muehlbauer S, Goldhirsch A, Untch M, Smith I, Baselga J, Jackisch C et al: Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial. The Lancet Oncology 2011, 12(3):236–244.GianniLDafniUGelberRDAzambujaEMuehlbauerSGoldhirschAUntchMSmithIBaselgaJJackischCTreatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trialThe Lancet Oncology201112323624410.1016/S1470-2045(11)70033-XSearch in Google Scholar
Harbeck N, Iyer S, Turner N, Cristofanilli M, Ro J, André F, Loi S, Verma S, Iwata H, Bhattacharyya H et al: Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial. Annals of Oncology 2016, 27(6):1047–1054.HarbeckNIyerSTurnerNCristofanilliMRoJAndréFLoiSVermaSIwataHBhattacharyyaHQuality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trialAnnals of Oncology20162761047105410.1093/annonc/mdw139488006527029704Search in Google Scholar
Winters ZE, Afzal M, Rutherford C, Holzner B, Rumpold G, da Costa Vieira RA, Hartup S, Flitcroft K, Bjelic-Radisic V, Oberguggenberger A et al: International validation of the European Organisation for Research and Treatment of Cancer QLQ-BRECON23 quality-of-life questionnaire for women undergoing breast reconstruction. British Journal of Surgery 2018, 105(3):209–222.WintersZEAfzalMRutherfordCHolznerBRumpoldGda Costa VieiraRAHartupSFlitcroftKBjelic-RadisicVOberguggenbergerAInternational validation of the European Organisation for Research and Treatment of Cancer QLQ-BRECON23 quality-of-life questionnaire for women undergoing breast reconstructionBritish Journal of Surgery2018105320922210.1002/bjs.1065629116657Search in Google Scholar
Bjelic-Radisic V, Cardoso F, Cameron D, Brain E, Kuljanic K, da Costa RA, Conroy T, Inwald EC, Serpentini S, Pinto M et al: An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45. Annals of oncology : official journal of the European Society for Medical Oncology 2020, 31(2):283–288.Bjelic-RadisicVCardosoFCameronDBrainEKuljanicKda CostaRAConroyTInwaldECSerpentiniSPintoMAn international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45Annals of oncology : official journal of the European Society for Medical Oncology202031228328810.1093/annonc/mdy270.267Search in Google Scholar
Raosoft sample size calculator [http://www.raosoft.com/samplesize.html]Raosoft sample size calculator[http://www.raosoft.com/samplesize.html]Search in Google Scholar
EORTC. EORTC Scoring Manual (Third Edition). 2001 [https://www.eortc.org/]EORTCEORTC Scoring Manual (Third Edition)2001[https://www.eortc.org/]Search in Google Scholar
Eortc Quality Of Life Group Translation Procedure, Fourth edition [https://www.eortc.org/app/uploads/sites/2/2018/02/translation_manual_2017.pdf]Eortc Quality Of Life Group Translation ProcedureFourth edition[https://www.eortc.org/app/uploads/sites/2/2018/02/translation_manual_2017.pdf]Search in Google Scholar
Beaton DE, Bombardier C, Guillemin F, Ferraz MB: Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 2000, 25(24):3186–3191.BeatonDEBombardierCGuilleminFFerrazMBGuidelines for the process of cross-cultural adaptation of self-report measuresSpine200025243186319110.1097/00007632-200012150-0001411124735Search in Google Scholar
Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, Franzini L, Williams A, de Haes HC, Hopwood P et al: The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 1996, 14(10):2756–2768.SprangersMAGroenvoldMArrarasJIFranklinJte VeldeAMullerMFranziniLWilliamsAde HaesHCHopwoodPThe European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field studyJ Clin Oncol199614102756276810.1200/JCO.1996.14.10.27568874337Search in Google Scholar
Cronbach LJJp: Coefficient alpha and the internal structure of tests. 1951, 16(3):297–334.CronbachLJJpCoefficient alpha and the internal structure of tests195116329733410.1007/BF02310555Search in Google Scholar
El Fakir S, Abda N, Bendahhou K, Zidouh A, Bennani M, Errihani H, Benider A, Bekkali R, Nejjari C: The European Organization for Research and Treatment of Cancer quality of life questionnaire-BR23 Breast Cancer-Specific Quality of Life Questionnaire: psychometric properties in a Moroccan sample of breast cancer patients. BMC research notes 2014, 7:53.El FakirSAbdaNBendahhouKZidouhABennaniMErrihaniHBeniderABekkaliRNejjariCThe European Organization for Research and Treatment of Cancer quality of life questionnaire-BR23 Breast Cancer-Specific Quality of Life Questionnaire: psychometric properties in a Moroccan sample of breast cancer patientsBMC research notes201475310.1186/1756-0500-7-53390689324447401Search in Google Scholar
Gadisa DA, Gebremariam ET, Ali GY: Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia. Health Qual Life Outcomes 2019, 17(1):182.GadisaDAGebremariamETAliGYReliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in EthiopiaHealth Qual Life Outcomes201917118210.1186/s12955-019-1257-z690957931830992Search in Google Scholar
Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M, Haji-Mahmoodi M: The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian version. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2000, 9(2):177–184.MontazeriAHarirchiIVahdaniMKhaleghiFJarvandiSEbrahimiMHaji-MahmoodiMThe EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian versionQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation20009217718410.1023/A:1008918310251Search in Google Scholar
Cerezo O, Oñate-Ocaña LF, Arrieta-Joffe P, González-Lara F, García-Pasquel MJ, Bargalló-Rocha E, Vilar-Compte D: Validation of the Mexican-Spanish version of the EORTC QLQ-C30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancer. European journal of cancer care 2012, 21(5):684–691.CerezoOOñate-OcañaLFArrieta-JoffePGonzález-LaraFGarcía-PasquelMJBargalló-RochaEVilar-CompteDValidation of the Mexican-Spanish version of the EORTC QLQ-C30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancerEuropean journal of cancer care201221568469110.1111/j.1365-2354.2012.01336.x22329843Search in Google Scholar
Demirci S, Eser E, Ozsaran Z, Tankisi D, Aras AB, Ozaydemir G, Anacak Y: Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients. Asian Pac J Cancer Prev 2011, 12(5):1283–1287.DemirciSEserEOzsaranZTankisiDArasABOzaydemirGAnacakYValidation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patientsAsian Pac J Cancer Prev201112512831287Search in Google Scholar
Chie WC, Chang KJ, Huang CS, Kuo WH: Quality of life of breast cancer patients in Taiwan: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-BR23. Psychooncology 2003, 12(7):729–735.ChieWCChangKJHuangCSKuoWHQuality of life of breast cancer patients in Taiwan: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-BR23Psychooncology200312772973510.1002/pon.72714502597Search in Google Scholar
Awad MA, Denic S, El Taji H: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires for Arabic-speaking Populations. Annals of the New York Academy of Sciences 2008, 1138:146–154.AwadMADenicSEl TajiHValidation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires for Arabic-speaking PopulationsAnnals of the New York Academy of Sciences2008113814615410.1196/annals.1414.02118837895Search in Google Scholar
Roshandel S, Lamyian M, Azin SA, Haghighat S, Mohammadi E: Development and validation of a guideline on sexual and reproductive health of breast cancer survivors in Iran: a mixed methods study protocol. Health Research Policy and Systems 2021, 19(1):87.RoshandelSLamyianMAzinSAHaghighatSMohammadiEDevelopment and validation of a guideline on sexual and reproductive health of breast cancer survivors in Iran: a mixed methods study protocolHealth Research Policy and Systems20211918710.1186/s12961-021-00738-6816600134059055Search in Google Scholar
Mikiyas Amare G, Panpan W, Eva Johanna K, Edom S, Changying C, Adamu A: Health Qual Life Outcomes 2021.Mikiyas AmareGPanpanWEva JohannaKEdomSChangyingCAdamuAHealth Qual Life Outcomes2021Search in Google Scholar
Brédart A, Marrel A, Abetz-Webb L, Lasch K, Acquadro C: Interviewing to develop Patient-Reported Outcome (PRO) measures for clinical research: eliciting patients’ experience. Health Qual Life Outcomes 2014, 12:15–15.BrédartAMarrelAAbetz-WebbLLaschKAcquadroCInterviewing to develop Patient-Reported Outcome (PRO) measures for clinical research: eliciting patients’ experienceHealth Qual Life Outcomes201412151510.1186/1477-7525-12-15393350924499454Search in Google Scholar